Meta-analysis on the association between pathologic complete response and triple-negative breast cancer after neoadjuvant chemotherapy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Surgery
Reference52 articles.
1. The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes
2. Pattern of metastatic spread in triple-negative breast cancer
3. Use of immunohistochemical markers can refine prognosis in triple negative breast cancer
4. Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342
5. Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Impact of Pathologic Complete Response on the Prognosis of Triple-Negative Breast Cancer Patients: A Cohort Study;Cureus;2023-04-10
2. MRI-Based Digital Models Forecast Patient-Specific Treatment Responses to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer;Cancer Research;2022-08-01
3. Assessment of Pathological Complete Response in Patients with Breast Cancer Receiving Neoadjuvant Systemic Therapy;Journal of the College of Physicians and Surgeons Pakistan;2022-06-01
4. Persistent EGFR/K-RAS/SIAH pathway activation drives chemo-resistance and early tumor relapse in triple-negative breast cancer;Cancer Drug Resistance;2022
5. Comparison of three standard neoadjuvant chemotherapy regimens based on pathological tumor response in breast cancer patients;PAK J PHARM SCI;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3